Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Kraft Foods Posts Higher Q4 Profit - Quick Facts

RELATED NEWS
Trade KRFT now with 

Kraft Foods Inc.'s (KFT: Quote) fourth-quarter net earnings attributable to the company climbed to $830 million or $0.47 per share from $540 million or $0.31 per share in the prior-year quarter.

Including a negative impact from foreign currency of $0.01, quarterly operating earnings per share amounted to $0.57 versus last year's $0.46. On average, 18 analysts polled by Thomson Reuters expected earnings per share of $0.57 for the quarter. Analysts' estimates typically exclude one-time items.

Net revenues for the fourth quarter were $14.69 billion, up 6.6 percent from $13.77 billion a year earlier, with organic net revenues up 6.1 percent. Analysts estimated revenues of $14.79 billion for the quarter

For 2012, Kraft Foods sees organic net revenue growth of nearly 5 percent, including a negative impact of up to one percentage point from product pruning in North America, with operating earnings per share anticipated to grow at least 9 percent on a constant currency basis, despite a higher effective tax rate and a 4 percentage point headwind from higher pension costs.

Further, the company said it would incur one-time restructuring, transition and transaction costs of $1.6 billion - $1.8 billion as it prepares to separate into two companies later this year. Also, the company anticipates that it may incur between $400 million and $800 million of potential debt breakage and financing fees as it executes a migration of debt to the North American grocery company.

Irene Rosenfeld, Chairman and CEO remarked, "We expect to deliver top-tier growth in 2012, in line with our long-term targets, while we prepare to successfully launch the North American grocery and global snacks companies later this year."

Register
To receive FREE breaking news email alerts for Kraft Foods Group Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.